Self-Testing Market to Show Major Growth Due to Globally Rising Adoption of These Test Kits
Overview:
Self-testing kits allow people to perform a variety
of tests in their homes or any private location without input from a healthcare
provider. These test kits involve collecting a sample of body fluid and
providing results quickly. Often these tests help diagnose pregnancy and screen
for chronic diseases like high blood pressure or diabetes and can offer
guidance on when to seek medical attention. While all self-testing test kits
require the user to swab the inside of their nose or throat, some of these test
kits are easier to use than others.
Market
Dynamics:
The rise in the adoption of self-testing kits is expected to
augment the growth of the global self-testing market over the forecast period. With
increase in consumer awareness regarding different medical products is leading
to a rise in a number of people preferring to perform basic tests at home using
test kits instead of visiting a doctor. For instance, in June 2022, Genes2Me
Pvt. Ltd. Introduced a CoviEasy Self-Testing Rapid Antigen test kit for COVID-19.
The new product offers ease of use and rapid results in 10 minutes.
However, high product recalls and lack of great
accuracy of products are the factors anticipated to hamper growth of the global
self-testing market over the forecast period.
Impact of
COVID-19:
The epidemic of COVID-19 impacted several industries
all over the world. Many countries imposed nationwide lockdowns to prevent the virus spread. During this period, hospital visits declined for other treatments
all over the world. With the increasing burden of COVID-19 patients, many
non-profit and government organizations began investments in self-testing kits
for COVID-19. As a result, there was a rise in product launches of self-testing
kits during the pandemic. Thus, the global self-testing market was positively
impacted by the outbreak of the COVID-19 pandemic.
Key
Takeaways:
· The
global
self-testing market is anticipated to grow with a CAGR of 8.7%
during the forecast period, owing to the increasing adoption of strategic
initiatives among market players such as acquisition and collaboration. For
instance, in February 2021, Becton Dickinson and Company collaborated with
Scanwell Health for developing an at-home rapid test for SARS-CoV-2 with the
use of an antigen test of Becton, Dickinson and Company, and the mobile app of Scanwell
Health. Such strategic activities among market players are likely to drive the growth of the market.
· Among
regions, North America is projected to show major growth in the global
self-testing market over the forecast period. This is owing to the growing role of
home test kits in value-based care. The region shows high awareness, and
increased adoption of self-testing kits. Thus, the market is likely to gain
significant growth in the region over the forecast future.
· Major
players functioning in the global self-testing market are True Diagnostics Inc.,
Becton, Dickinson and Company, InBios International, Inc. USA., Abbott, iHealth
Labs Inc., ACCESS BIO, Btnx Inc., CELLTRION INC., Bionime Corporation, Siemens
Healthcare GmbH, Quest Diagnostics, ACON Laboratories Inc., OraSure
Technologies Inc., ARKRAY, Inc., And F. Hoffmann-La Roche Ltd.
Comments
Post a Comment